| I-047 Andrew Butler Exploration of CPRD and Yellow Card real-world data to support efficacy and safety targets for levonorgestrel contraceptives. Wednesday 10:20-11:50 |
| I-067 Heather Collis A case study of applying machine learning to improve non-invasive assessment of fibrosis stage in MASLD Wednesday 10:20-11:50 |
| I-076 Alessandro De Carlo PopPK-PD modelling of Carboplatin-induced myelosuppression to support therapeutic drug monitoring and dose individualization in cancer patients using Electronic Health Record Data Wednesday 10:20-11:50 |
| II-011 Verena Gotta Anemia control under maintenance hemodialysis (HD) and association with long-term outcome in pediatric and adolescent patients – a real-world data analysis Wednesday 15:20-16:50 |
| II-038 Thomas Henthorn Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled ?9-Tetrahydrocannabinol (THC) Cannabis Market Products in Occasional and Daily Users Wednesday 15:20-16:50 |
| III-006 Wen Yao Mak Population repeated time-to-event analysis of peritonitis in end-stage renal failure: Predicting the natural progression and infection risk through nationwide registry data Thursday 09:50-11:20 |
| III-023 Lyndsey Meyer Advancing Quantitative Systems Pharmacology (QSP) Disease Progression Modeling with Real-World Data: Applications for Patients with Unintentional Weight Loss Thursday 09:50-11:20 |
| IV-006 Valerie Sia Aging-related CYP3A functional changes: Novel findings from a model-based assessment of real-world pharmacokinetic study in Chinese older inpatients Thursday 15:00-16:30 |
| IV-026 Budi Octasari Susanto An integrative translational framework for in vitro modelling for macozinone to support prediction of early human anti-tubercular efficacy Thursday 15:00-16:30 |
| IV-057 Martje Van Neste A semi-systematic review on the maturational physiology in exclusively breastfed infants: Growth – A contribution from the ConcePTION project Thursday 15:00-16:30 |
